.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Chubb
US Department of Justice
Harvard Business School
Cerilliant
Moodys
Express Scripts
Accenture
McKesson
Novartis

Generated: June 22, 2017

DrugPatentWatch Database Preview

Sacubitril; valsartan - Generic Drug Details

« Back to Dashboard

What are the generic sources for sacubitril; valsartan and what is the scope of sacubitril; valsartan patent protection?

Sacubitril; valsartan
is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sacubitril; valsartan has seventy-nine patent family members in thirty-six countries.

There is one drug master file entry for sacubitril; valsartan. One supplier is listed for this compound.

Summary for Generic Name: sacubitril; valsartan

Tradenames:1
Patents:7
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Suppliers / Packagers: see list1
Clinical Trials: see list263
Drug Prices:see low prices
DailyMed Link:sacubitril; valsartan at DailyMed

Pharmacology for Ingredient: sacubitril; valsartan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
ENTRESTO
sacubitril; valsartan
TABLET;ORAL207620-002Jul 7, 2015RXYesNo7,468,390► SubscribeY ► Subscribe
Novartis Pharms Corp
ENTRESTO
sacubitril; valsartan
TABLET;ORAL207620-003Jul 7, 2015RXYesYes8,101,659► SubscribeY ► Subscribe
Novartis Pharms Corp
ENTRESTO
sacubitril; valsartan
TABLET;ORAL207620-002Jul 7, 2015RXYesNo8,877,938► SubscribeYY ► Subscribe
Novartis Pharms Corp
ENTRESTO
sacubitril; valsartan
TABLET;ORAL207620-001Jul 7, 2015RXYesNo8,404,744► SubscribeY ► Subscribe
Novartis Pharms Corp
ENTRESTO
sacubitril; valsartan
TABLET;ORAL207620-001Jul 7, 2015RXYesNo8,877,938► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sacubitril; valsartan

Country Document Number Estimated Expiration
Netherlands300811► Subscribe
Peru08032007► Subscribe
South Korea20080075055► Subscribe
CroatiaP20140274► Subscribe
Spain2290429► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SACUBITRIL; VALSARTAN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2016000038Germany► SubscribePRODUCT NAME: SACUBITRIL/VALSARTAN, ALS SACUBITRIL VALSARTAN NATRIUM SALZKOMPLEX, D.H. TRINATRIUM-(3-((1 S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONAT-(S)-3'-METHYL-2'-(PENTANOYL-(2"-(TETRAZOL-5-YLAT)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRAT)-HEMIPENTAHYDRAT.; REGISTRATION NO/DATE: EU/1/15/1058 20151119
2016000037Germany► SubscribePRODUCT NAME: SACUBITRIL/VALSARTAN, EINSCHLIESSIICH PHARMAZEUTISCH ANNEHMBARER SALZE DAVON; REGISTRATION NO/DATE: EU/1/15/1058 20151119
074Luxembourg► SubscribePRODUCT NAME: SACUBITRIL/VALSARTAN, Y COMPRIS LES SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI; FIRST REGISTRATION DATE: 20151123
/2016Austria► SubscribePRODUCT NAME: SACUBITRIL/VALSARTAN, EINSCHLIESSLICH PHARMAZEUTISCH ANNEHMBARE SALZE DAVON; REGISTRATION NO/DATE: EU/1/15/1058 20151119
2016017Lithuania► SubscribePRODUCT NAME: SAKUBITRILAS/VALSARTANAS; REGISTRATION NO/DATE: EU/1/15/1058 20151119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
McKinsey
McKesson
Merck
Medtronic
Cipla
Fish and Richardson
Queensland Health
Baxter
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot